Walleye Trading LLC Glaukos Corp Transaction History

Walleye Trading LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$40.82 - $57.75 $476,900 - $674,693	-11,683 Reduced 70.77%	4,825 $210,000
Q3 2022 Nov 14, 2022	BUY	$46.84 - $58.49 $773,234 - $965,552	16,508 New	16,508 $879,000
Q2 2022 Aug 08, 2022	SELL	$34.86 - $63.77 $51,941 - $95,017	-1,490 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$44.33 - $57.82 $66,051 - $86,151	1,490 New	1,490 $86,000
Q4 2021 Feb 14, 2022	SELL	$40.27 - $56.99 $160,435 - $227,048	-3,984 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$47.43 - $84.23 $107,144 - $190,275	2,259 Added 130.96%	3,984 $192,000
Q4 2020 Feb 16, 2021	BUY	$48.9 - $75.26 $84,352 - $129,823	1,725 New	1,725 $130,000

340

47.1M

132K

188K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $6.85B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.